| Financial Year |
March 31 2023 |
| Monetary Funds |
909,780,875.60 |
| Held-for-trading Financial Assets |
452,314,053.02 |
| Notes Receivable |
-- |
| Accounts Receivable |
516,198,913.35 |
| Advances to Suppliers |
31,736,784.80 |
| Other Receivables |
4,437,225.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
119,868,682.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,658,313.56 |
| Total Current Assets |
2,076,088,748.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
136,003,581.82 |
| Under-construction Projects |
16,986,597.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,833,382.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,867,724.67 |
| Deferred Income Tax Assets |
4,704,990.67 |
| Other Non-Current Assets |
12,346,122.35 |
| Sub-Total of Non-Current Assets |
593,866,356.25 |
| Total Assets |
2,669,955,104.29 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
316,156,532.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,609,174.04 |
| Taxes Payable |
14,367,426.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,809,591.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,374,748.59 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
399,317,473.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,196,571.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,740,051.52 |
| Total Liabilities |
470,057,524.67 |
| Paid-In Capital(Or Share Stock) |
120,672,000.00 |
| Capital Surplus |
1,466,458,884.91 |
| Surplus Reserve |
60,336,000.00 |
| LESS:Treasury Stock |
15,691,200.00 |
| Undistributed Profits |
543,047,430.18 |
| Minority Stockholder's Interest |
25,074,464.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,174,823,115.09 |
| Owner's Equity（Stockholder's Equity） |
2,199,897,579.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,669,955,104.29 |
